Collaboration is a key component to achieving long-term success with genetic medicines.
John Lewis
Advertisement
John Lewis, PhD, is CEO of Entos Pharmaceuticals.
Articles by John Lewis
Advertisement
Latest Updated Articles
Risks and Rewards of Investing in RNA-based Genetic Medicine ManufacturingPublished: December 3rd 2023 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Drug Digest: Strategic Alliances and Technology Integration in the Evolving Biopharma Landscape
2
Clearing Hurdles in Sustainability, AI, and CDMO Partnerships
3
Dosage Form Innovations: A CPHI Frankfurt Conversation with Lonza’s Frank Romanski, Part One
4
PharmTech Weekly News Roundup — Week of October 27, 2025
5
